Stocks
BioNTech SEBNTX
NASDAQHealthcareBiotechnology$91.19+1.21%
A Germany-based biotechnology company focused on developing mRNA-based therapies and vaccines, including cancer immunotherapies and infectious disease treatments. It gained global prominence through its partnership with Pfizer to develop one of the first widely deployed COVID-19 vaccines, which gene...
Market Cap: $22.9B52W Range: $79.52 – $124.00
Congressional Interest in BioNTech SE (BNTX)
4 members of Congress have disclosed 13 trades in BioNTech SE (BNTX), a Healthcare company. The buy/sell breakdown shows 8 purchases versus 5 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
13
Unique Politicians
4
Buys
8
Sells
5
Who in Congress Is Trading BNTX?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-08-07 | Valerie Hoyle | sell | $1K – $15K |
| 2024-09-03 | Josh Gottheimer | sell | $1K – $15K |